BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 7802694)

  • 21. Mobilization of gastric histamine during repeated administration of a proton potassium adenosine triphosphatase inhibitor in intact and antrectomized rats.
    Miyazaki Y; Shinomura Y; Higashimoto Y; Imamura I; Fukui H; Aoki T; Okuda Y; Narita T; Miwa K; Miyazaki I
    Regul Pept; 1995 Jul; 58(1-2):47-54. PubMed ID: 8570859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry.
    Shimatani T; Inoue M; Kuroiwa T; Xu J; Tazuma S; Horikawa Y; Nakamura M
    Dig Dis Sci; 2005 Jul; 50(7):1202-6. PubMed ID: 16047460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in the rat stomach after long-term administration of proton pump inhibitors (AG-1749 and E-3810)].
    Kawai T; Ikeda H; Harada Y; Saitou T
    Nihon Rinsho; 1992 Jan; 50(1):188-93. PubMed ID: 1311785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18-5364 to inhibit gastric H+, K(+)-ATPase is correlatedwith the rate of acid-activation of the inhibitor.
    Morii M; Takata H; Fujisaki H; Takeguchi N
    Biochem Pharmacol; 1990 Feb; 39(4):661-7. PubMed ID: 2154989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation.
    Ishizaki T; Chiba K; Manabe K; Koyama E; Hayashi M; Yasuda S; Horai Y; Tomono Y; Yamato C; Toyoki T
    Clin Pharmacol Ther; 1995 Aug; 58(2):155-64. PubMed ID: 7648765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
    Hori Y; Matsukawa J; Takeuchi T; Nishida H; Kajino M; Inatomi N
    J Pharmacol Exp Ther; 2011 Jun; 337(3):797-804. PubMed ID: 21411494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
    Fellenius E; Berglindh T; Sachs G; Olbe L; Elander B; Sjöstrand SE; Wallmark B
    Nature; 1981 Mar; 290(5802):159-61. PubMed ID: 6259537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative pharmacokinetic/pharmacodynamic analysis of proton pump inhibitors omeprazole, lansoprazole and pantoprazole, in humans.
    Katashima M; Yamamoto K; Tokuma Y; Hata T; Sawada Y; Iga T
    Eur J Drug Metab Pharmacokinet; 1998; 23(1):19-26. PubMed ID: 9625268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of proton pump inhibitors on thyroid hormone metabolism in rats: a comparison of UDP-glucuronyltransferase induction.
    Masubuchi N; Hakusui H; Okazaki O
    Biochem Pharmacol; 1997 Dec; 54(11):1225-31. PubMed ID: 9416973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric antisecretory activity of lansoprazole in different experimental models: comparison with omeprazole.
    Coruzzi G; Adami M; Bertaccini G
    Gen Pharmacol; 1995 Sep; 26(5):1027-32. PubMed ID: 7557245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.
    Blandizzi C; Natale G; Gherardi G; Lazzeri G; Marveggio C; Colucci R; Carignani D; Del Tacca M
    Dig Dis Sci; 1999 Oct; 44(10):2039-50. PubMed ID: 10548356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of rabeprazole (E3810), a novel proton pump inhibitor, on intragastric pH in healthy volunteers.
    Hongo M; Kimpara T; Moriyama S; Ohara S; Sone S; Tamura T; Asaki S; Toyota T
    Tohoku J Exp Med; 1998 Sep; 186(1):43-50. PubMed ID: 9915106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of rabeprazole, a gastric proton pump inhibitor, on biliary and hepatic lysosomal enzymes in rats.
    Fujisaki H; Oketani K; Nagakawa J; Takenaka O; Yamanishi Y
    Jpn J Pharmacol; 1998 Mar; 76(3):279-88. PubMed ID: 9593221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases.
    Hori Y; Imanishi A; Matsukawa J; Tsukimi Y; Nishida H; Arikawa Y; Hirase K; Kajino M; Inatomi N
    J Pharmacol Exp Ther; 2010 Oct; 335(1):231-8. PubMed ID: 20624992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
    Nagaya H; Satoh H; Kubo K; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):799-805. PubMed ID: 2537417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
    Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
    Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of NC-1300-B, a new benzimidazole derivative, on hog gastric H+, K+-ATPase, gastric acid secretion and HCl.ethanol-induced gastric lesions in rats.
    Okabe S; Akimoto Y; Yamasaki S; Nagai H
    Dig Dis Sci; 1988 Nov; 33(11):1425-34. PubMed ID: 2846250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial potency of lansoprazole and omeprazole tablets on pentagastrin-stimulated gastric acid secretion-a placebo-controlled study in healthy volunteers.
    Müller P; Göksu MA; Fuchs W; Schlüter F; Simon B
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1225-9. PubMed ID: 10971240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of a new H(+)-K+ ATPase inhibitor (E3810) and its four metabolites in human plasma by high-performance liquid chromatography.
    Nakai H; Shimamura Y; Kanazawa T; Yasuda S; Kayano M
    J Chromatogr B Biomed Appl; 1994 Oct; 660(1):211-20. PubMed ID: 7858718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.